Efficacy of Pembrolizumab as Second or Third-line Therapy for Local Advanced and Metastatic Urothelial Cancer. Matsuo T, Miyata Y, Harada J, Itoh I, et al. Anticancer Res 2025;45:2563-2573.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Matsuo T, Miyata Y, Harada J, Itoh I, et al. Efficacy of Pembrolizumab as Second or Third-line Therapy for Local Advanced and Metastatic Urothelial Cancer. Anticancer Res 2025;45:2563-2573.
PMID: 40425336